- Company
- Products
- Catalogs
- News & Trends
- Exhibitions
Rapid infectious disease test COVID-19for antigensSARS-COV-2
Add to favorites
Compare this product
Characteristics
- Applications
- for infectious diseases, COVID-19
- Tested parameter
- for antigens
- Micro-organism
- SARS-COV-2, RSV
- Sample type
- nasal
- Analysis mode
- immunofluorescence
- Format
- strip
- Result display time
12 min
Description
Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.
Test benefits
Helps guide infection control measures quickly
Prepared sample can also be used with LumiraDx SARS-Cov-2 & Flu A/B Test
Easy to implement at point of care
No refrigeration storage required: room temperature storage (2-30°C)
Minimal handling steps
Small and portable Instrument
Test workflow
The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.
Catalogs
No catalogs are available for this product.
See all of LumiraDx‘s catalogs
Related Searches
- Assay kit
- LumiraDx rapid blood test
- Immunoassay rapid diagnostic test
- Respiratory infection test kit
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Clinical assay kit
- Whole blood rapid diagnostic test
- Infectious disease rapid diagnostic test
- COVID-19 assay kit
- LumiraDx rapid respiratory disease test
- Antigen assay kit
- LumiraDx COVID-19 rapid test
- Strip assay kit
- Veterinary detection kit
- LumiraDx strip rapid test
- Nasopharyngeal assay kit
- Immunofluorescence test kit
- Clinical rapid diagnostic test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.